Guidance

Phenylketonuria (PKU): summary

Updated 18 November 2021

Applies to England

© Crown copyright 2021

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/pku-suspected-description-in-brief/pku-suspected

Public Health England (PHE) created this information on behalf of the NHS. In it, the word ‘we’ refers to the NHS service that provides screening.

This information is for parents if their baby is suspected of having PKU or has been diagnosed with PKU following their newborn blood spot screening test (‘heel prick test’). It will help you and your health professionals to talk through the next stages of your baby’s care.

About PKU

Phenylketonuria (pronounced as fee-nile-key-tone-you-ree-ah), or PKU, is a rare but treatable inherited metabolic disorder that prevents the normal breakdown of protein. Babies with PKU inherit 2 faulty copies of the gene for PKU, one from each parent.

Untreated PKU can lead to long-term health problems, including severe learning difficulties and behavioural problems, but with newborn screening and early treatment this can be prevented.

Screening and diagnosis of PKU

Newborn blood spot (‘heel prick test’)

When your baby was about 5 days old, your midwife took some blood from your baby’s heel for their newborn blood spot screening test (the ‘heel prick test’). The newborn blood spot screening test measures the amount of some amino acids in the blood. A high level of the amino acid phenylalanine suggests your baby may have PKU. This is called a screen positive result.

Diagnostic tests

If your baby has a screen positive result, you will be seen by a metabolic doctor, dietitian and nurse specialist (the ‘metabolic team’). The team will provide advice and support. Blood tests will be carried out to confirm if your baby has PKU.

You will need to wait a few days for the test results to be reported. During this time, you can continue to breastfeed or give normal infant formula.

Treatment

If your baby does have PKU, the metabolic team will explain the condition in more detail and answer any questions you might have. They will start your baby on a special diet (to restrict phenylalanine intake), and they will arrange regular follow-up appointments. Following the diet is very important for your baby’s health.

Confidentiality

The NHS screening programmes use personal information from your NHS records to invite you for screening at the right time. Public Health England also uses your information to ensure you receive high quality care and to improve the screening programmes. Find out more about how your information is used and protected, and your options.

More information and support

The metabolic team will be happy to discuss any queries you may have.

For more information, see Phenylketonuria (PKU): further information.

Further information can be found at Metabolic Support UK. The Metabolic Support UK team can be contacted at:

The National Society for Phenylketonuria (NSPKU) also provides information and support. The NSPKU team can be contacted on:

The British Inherited Metabolic Diseases Group (BIMDG) website has a TEMPLE booklet about PKU.

NHS.UK has information about PKU and newborn blood spot screening.

Back to top